| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5763454 | PFIZER | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Jun, 2015
(8 years ago) | |
| US6080756 | PFIZER | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
Jul, 2016
(7 years ago) | |
| US6194429 | PFIZER | Alatrofloxacin parenteral compositions |
Jul, 2018
(5 years ago) | |
Trovan Preservative Free is owned by Pfizer.
Trovan Preservative Free contains Alatrofloxacin Mesylate.
Trovan Preservative Free has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Trovan Preservative Free are:
- US5763454
- US6080756
- US6194429
Trovan Preservative Free was authorised for market use on 18 December, 1997.
Trovan Preservative Free is available in injectable;injection dosage forms.
Trovan Preservative Free can be used as method of treating bacterial infections.
The generics of Trovan Preservative Free are possible to be released after 23 July, 2018.
Drugs and Companies using ALATROFLOXACIN MESYLATE ingredient
Market Authorisation Date: 18 December, 1997
Treatment: Method of treating bacterial infections
Dosage: INJECTABLE;INJECTION
TROVAN PRESERVATIVE FREE family patents
